Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections

Abstract

In hematological malignancy patients without an available HLAidentical sibling or matched unrelated donor, the use of T-cell replete related donor haploidentical hematopoietic cell transplantation (haplo-HCT), using post-transplant cyclophosphamide (PT-Cy) as GvHD prophylaxis, is rapidly increasing. PT-Cy mitigates the risk of GvHD by targeting alloreactive… (More)
DOI: 10.1038/bmt.2016.216

Topics

2 Figures and Tables

Slides referencing similar topics